NO996270D0 - Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor - Google Patents

Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor

Info

Publication number
NO996270D0
NO996270D0 NO996270A NO996270A NO996270D0 NO 996270 D0 NO996270 D0 NO 996270D0 NO 996270 A NO996270 A NO 996270A NO 996270 A NO996270 A NO 996270A NO 996270 D0 NO996270 D0 NO 996270D0
Authority
NO
Norway
Prior art keywords
thiazolidinedione
alfa
diabetes
treatment
glucosidase inhibitor
Prior art date
Application number
NO996270A
Other languages
English (en)
Norwegian (no)
Other versions
NO996270L (no
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712865.6A external-priority patent/GB9712865D0/en
Priority claimed from GBGB9806708.5A external-priority patent/GB9806708D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO996270L publication Critical patent/NO996270L/no
Publication of NO996270D0 publication Critical patent/NO996270D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
NO996270A 1997-06-18 1999-12-17 Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor NO996270D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9712865.6A GB9712865D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806708.5A GB9806708D0 (en) 1998-03-27 1998-03-27 Novel method
PCT/EP1998/003691 WO1998057635A1 (en) 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor

Publications (2)

Publication Number Publication Date
NO996270L NO996270L (no) 1999-12-17
NO996270D0 true NO996270D0 (no) 1999-12-17

Family

ID=26311746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996270A NO996270D0 (no) 1997-06-18 1999-12-17 Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor

Country Status (24)

Country Link
EP (1) EP0975343A1 (ko)
JP (1) JP2001523271A (ko)
KR (1) KR20010013845A (ko)
CN (1) CN1274282A (ko)
AP (1) AP9901720A0 (ko)
AR (2) AR014881A1 (ko)
AU (1) AU8799998A (ko)
BG (1) BG103966A (ko)
BR (1) BR9810186A (ko)
CA (1) CA2294134A1 (ko)
CO (1) CO4940453A1 (ko)
DZ (1) DZ2519A1 (ko)
EA (1) EA200000040A1 (ko)
IL (1) IL133138A0 (ko)
MA (1) MA26510A1 (ko)
NO (1) NO996270D0 (ko)
NZ (1) NZ501345A (ko)
OA (1) OA11631A (ko)
PE (1) PE89199A1 (ko)
PL (1) PL337577A1 (ko)
SK (1) SK179499A3 (ko)
TR (1) TR199903072T2 (ko)
UY (1) UY25051A1 (ko)
WO (1) WO1998057635A1 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100744359B1 (ko) 1999-04-23 2007-07-30 스미스클라인비이참피이엘시이 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
JP4590159B2 (ja) 2001-04-04 2010-12-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド グルコース再吸収阻害剤およびｐｐａｒモジュレーターを含んで成る併用療法
EP1392326B1 (en) 2001-04-04 2009-09-09 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP2004067575A (ja) * 2002-08-06 2004-03-04 Yaizu Suisankagaku Industry Co Ltd 糖尿病治療薬効果促進剤
CN101121004B (zh) * 2006-08-08 2010-07-21 鲁南制药集团股份有限公司 含有胰岛素增敏剂和米格列醇的药物组合物
CN101584688B (zh) * 2008-05-24 2010-11-10 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物
CN101584705B (zh) * 2008-05-24 2010-10-27 鲁南制药集团股份有限公司 一种治疗糖尿病及其并发症的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900435A (en) * 1991-08-26 1999-05-04 Pharmacia & Upjohn Company Composition, food product and uses of 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
AR013352A1 (es) 2000-12-27
CA2294134A1 (en) 1998-12-23
MA26510A1 (fr) 2004-12-20
KR20010013845A (ko) 2001-02-26
NO996270L (no) 1999-12-17
AP9901720A0 (en) 1999-12-31
BG103966A (bg) 2000-07-31
OA11631A (en) 2004-11-22
WO1998057635A1 (en) 1998-12-23
AR014881A1 (es) 2001-04-11
CN1274282A (zh) 2000-11-22
AU8799998A (en) 1999-01-04
TR199903072T2 (xx) 2000-07-21
UY25051A1 (es) 2000-09-29
PL337577A1 (en) 2000-08-28
DZ2519A1 (fr) 2003-02-01
PE89199A1 (es) 1999-10-23
EA200000040A1 (ru) 2000-08-28
CO4940453A1 (es) 2000-07-24
BR9810186A (pt) 2000-08-08
EP0975343A1 (en) 2000-02-02
IL133138A0 (en) 2001-03-19
NZ501345A (en) 2001-10-26
JP2001523271A (ja) 2001-11-20
SK179499A3 (en) 2000-11-07

Similar Documents

Publication Publication Date Title
DK0996444T3 (da) Behandling af diabetes med thiazolidindion og metformin
DK1228067T3 (da) 5-leddede heterocykliske forbindelser med hypoglykæmisk og hypolipidæmisk virkning
NO20006178D0 (no) Anvendelse av PEG-IFN-&lt;alfa&gt; og ribavirin for behandling av kronisk hepatitt C
NO984094L (no) Utladningsreaktor og anvendelse av samme
DK0863721T3 (da) Elektronisk stetoskop med idealiserede klokke- og membrantilstande
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
NO996265L (no) Behandling av diabetes med rosiglitazon og insulin
FI963611A0 (fi) Diabeettisen munuaissairauden hoito valsartaanilla
NO996270D0 (no) Behandling av diabetes med tiazolidindion og &lt;alfa&gt;- glukosidaseinhibitor
NO20000230D0 (no) Behandling av diabetes med tiazolidindion, insulin sekretagogue og &lt;alfa&gt;glukosidaseinhibitor
ATE268327T1 (de) Benzazol-verbindungen und ihre verwendung
NO996264D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO20000229L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO955258D0 (no) Medisinsk anvendelse av enzymer
NO20003439D0 (no) N-oksyder av heterocykliske forbindelser med TNF og PDE-IV inhibiterende aktivitet
ID24355A (id) Pengobatan diabetes mellitus dengan tiazolidinadion dan inhibitor alfa-glukosidase
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
NO963869D0 (no) Behandling av diabetisk nefropati med valsartan
NO20014454D0 (no) Konstruksjon og anvendelse av samme
SE9603101D0 (sv) Medicinsk användning av enzym
NO930644D0 (no) Absorpsjonsmiddel og anvendelse av dette

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application